ERLOTINIB

NDC 31722-263 · Camber Pharmaceuticals, Inc.

Generic nameERLOTINIB

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)ERLOTINIB HYDROCHLORIDE

Strength25 mg/1

Pharmacologic classKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]

Marketing categoryANDA

Packages

31722-263-30 — 1 BOTTLE in 1 CARTON (31722-263-30) / 30 TABLET, FILM COATED in 1 BOTTLE

FDA lists these products with the same active ingredient.

0093-7662 — Erlotinib, 0093-7663 — Erlotinib, 0093-7664 — Erlotinib, 31722-264 — ERLOTINIB, 31722-265 — ERLOTINIB, 46708-565 — ERLOTINIB HYDROCHLORIDE, 46708-566 — ERLOTINIB HYDROCHLORIDE, 46708-567 — ERLOTINIB HYDROCHLORIDE, 59651-530 — Erlotinib, 59651-531 — Erlotinib, 59651-532 — Erlotinib, 62332-565 — ERLOTINIB HYDROCHLORIDE, 62332-566 — ERLOTINIB HYDROCHLORIDE, 62332-567 — ERLOTINIB HYDROCHLORIDE, 68382-913 — Erlotinib, 68382-914 — Erlotinib, 68382-915 — Erlotinib, 70771-1521 — Erlotinib, 70771-1522 — Erlotinib, 70771-1523 — Erlotinib, +6 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.